• The class of molecules behind one of biotech's biggest Alzheimer's failures gets a new lease on life

    2 monthes ago - By San Diego Biotechnology

    Denovo Biopharma has spent the last decade trying to resurrect drugs that failed at other companies, but it had never waded into a class of molecules that failed quite as spectacularly as 5HT6 serotonin, an oft-failed shot on goal in Alzheimer's. But, in the wake of Biogen's derided success with...
    Read more ...